Viewpoint: FDA ‘accelerated’ drug approvals offer relief for critically ill patients. But more could be done.

Desperately-needed therapies often warrant early approvals ...

Who benefits most from FDA’s ‘accelerated’ drug approvals? Patients or drugmakers?

Increasing reliance on this and other means of moving drugs quickly to market have many critics worried, given that drugmakers ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists